Capital Analysts LLC’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Sell |
118
-300
| -72% | -$48.3K | ﹤0.01% | 1028 |
|
|
2025
Q1 | $71K | Buy |
+418
| New | +$71K | ﹤0.01% | 719 |
|
|
2024
Q3 | – | Sell |
-1,557
| Closed | -$240K | – | 1325 |
|
|
2024
Q2 | $240K | Hold |
1,557
| – | – | 0.01% | 433 |
|
|
2024
Q1 | $239K | Hold |
1,557
| – | – | 0.01% | 412 |
|
|
2023
Q4 | $246K | Sell |
1,557
-100
| -6% | -$15.8K | 0.01% | 395 |
|
|
2023
Q3 | $243K | Sell |
1,657
-1,757
| -51% | -$258K | 0.01% | 372 |
|
|
2023
Q2 | $523K | Sell |
3,414
-50
| -1% | -$7.66K | 0.03% | 288 |
|
|
2023
Q1 | $537K | Sell |
3,464
-90
| -3% | -$14K | 0.03% | 287 |
|
|
2022
Q4 | $548K | Sell |
3,554
-179
| -5% | -$27.6K | 0.03% | 284 |
|
|
2022
Q3 | $493K | Buy |
3,733
+1,721
| +86% | +$227K | 0.03% | 270 |
|
|
2022
Q2 | $273K | Hold |
2,012
| – | – | 0.02% | 313 |
|
|
2022
Q1 | $300K | Hold |
2,012
| – | – | 0.02% | 307 |
|
|
2021
Q4 | $326K | Hold |
2,012
| – | – | 0.02% | 301 |
|
|
2021
Q3 | $334K | Hold |
2,012
| – | – | 0.02% | 296 |
|
|
2021
Q2 | $347K | Sell |
2,012
-4,360
| -68% | -$752K | 0.02% | 283 |
|
|
2021
Q1 | $1.02M | Sell |
6,372
-3,661
| -36% | -$588K | 0.07% | 199 |
|
|
2020
Q4 | $1.69M | Buy |
10,033
+45
| +0.5% | +$7.56K | 0.15% | 125 |
|
|
2020
Q3 | $1.57M | Buy |
9,988
+328
| +3% | +$51.6K | 0.15% | 120 |
|
|
2020
Q2 | $1.62M | Buy |
9,660
+1,775
| +23% | +$298K | 0.17% | 109 |
|
|
2020
Q1 | $1.03M | Buy |
7,885
+7,828
| +13,733% | +$1.03M | 0.13% | 138 |
|
|
2019
Q4 | $8K | Sell |
57
-341
| -86% | -$47.9K | ﹤0.01% | 571 |
|
|
2019
Q3 | $49K | Buy |
398
+57
| +17% | +$7.02K | 0.01% | 387 |
|
|
2019
Q2 | $48K | Hold |
341
| – | – | 0.01% | 374 |
|
|
2019
Q1 | $51K | Buy |
+341
| New | +$51K | 0.01% | 342 |
|